MA34975B1 - Composition d'inhibiteur viral pour une utilisation therapeutique in vivo. - Google Patents
Composition d'inhibiteur viral pour une utilisation therapeutique in vivo.Info
- Publication number
- MA34975B1 MA34975B1 MA36264A MA36264A MA34975B1 MA 34975 B1 MA34975 B1 MA 34975B1 MA 36264 A MA36264 A MA 36264A MA 36264 A MA36264 A MA 36264A MA 34975 B1 MA34975 B1 MA 34975B1
- Authority
- MA
- Morocco
- Prior art keywords
- therapeutic use
- inhibitor composition
- vivo therapeutic
- viral inhibitor
- viral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
- A01N35/04—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aldehyde or keto groups, or thio analogues thereof, directly attached to an aromatic ring system, e.g. acetophenone; Derivatives thereof, e.g. acetals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
- A01N37/38—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system
- A01N37/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system having at least one carboxylic group or a thio analogue, or a derivative thereof, and one oxygen or sulfur atom attached to the same aromatic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/24—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
- C07C49/245—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings
- C07C49/248—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Dentistry (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Biotechnology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La présente invention concerne une composition pharmaceutique comprenant un composé de formule A, soit (2,3(dihydroxy), 5[3(1,2)butadiène], 1(3hydroxy,3méthyl,4pentène) benzène) et/ou un composé de formule B, soit (2,3(dihydroxy), 5[3(1,2)butadiène]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2011/054758 WO2011117424A1 (fr) | 2010-03-26 | 2011-03-28 | Compositions inhibitrices virales pour une utilisation thérapeutique in vivo comprenant une combinaison de (-)-carvone, de géraniol et d'un autre composant d'huile essentielle |
PCT/EP2011/066746 WO2012038553A1 (fr) | 2011-03-28 | 2011-09-27 | Composition d'inhibiteur viral pour une utilisation thérapeutique in vivo |
Publications (1)
Publication Number | Publication Date |
---|---|
MA34975B1 true MA34975B1 (fr) | 2014-03-01 |
Family
ID=44677899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA36264A MA34975B1 (fr) | 2011-03-28 | 2011-09-27 | Composition d'inhibiteur viral pour une utilisation therapeutique in vivo. |
Country Status (26)
Country | Link |
---|---|
US (1) | US9315448B2 (fr) |
EP (1) | EP2691088B1 (fr) |
JP (1) | JP5701445B2 (fr) |
KR (1) | KR101818286B1 (fr) |
CN (1) | CN103458883B (fr) |
AU (1) | AU2011306879B2 (fr) |
BR (1) | BR112013024457A2 (fr) |
CA (1) | CA2830703C (fr) |
CO (1) | CO6771455A2 (fr) |
DK (1) | DK2691088T3 (fr) |
EA (1) | EA025610B1 (fr) |
ES (1) | ES2538011T3 (fr) |
HK (1) | HK1188715A1 (fr) |
HR (1) | HRP20150596T1 (fr) |
IL (1) | IL228444A (fr) |
MA (1) | MA34975B1 (fr) |
MX (1) | MX2013011242A (fr) |
NZ (1) | NZ615613A (fr) |
PL (1) | PL2691088T3 (fr) |
PT (1) | PT2691088E (fr) |
RS (1) | RS54022B1 (fr) |
SG (1) | SG193426A1 (fr) |
SI (1) | SI2691088T1 (fr) |
SM (1) | SMT201500131B (fr) |
UA (1) | UA110512C2 (fr) |
WO (1) | WO2012038553A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112280750B (zh) * | 2020-10-22 | 2022-11-01 | 山东农业大学 | 具有跨种传播能力的新型鹅星状病毒及其应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU78955A1 (de) | 1978-01-27 | 1979-09-06 | Chimicasa Gmbh | Verfahren zur inaktivierung von viren |
US4902678A (en) | 1982-02-12 | 1990-02-20 | Syntex (U.S.A.) Inc. | Anti-viral compositions |
US5128353A (en) * | 1985-06-20 | 1992-07-07 | University Of Florida | Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment |
US5856364A (en) | 1991-03-01 | 1999-01-05 | Warner Lambert Company | Therapeutic antiviral-wound healing compositions and methods for preparing and using same |
WO2002056879A1 (fr) | 2001-01-03 | 2002-07-25 | Medpharma Plc | Utilisation de terpenes dans le traitement des infections du tube digestif |
US20040071757A1 (en) | 2001-11-20 | 2004-04-15 | David Rolf | Inhalation antiviral patch |
-
2011
- 2011-09-27 KR KR1020137027360A patent/KR101818286B1/ko active IP Right Grant
- 2011-09-27 SI SI201130509T patent/SI2691088T1/sl unknown
- 2011-09-27 PT PT117610857T patent/PT2691088E/pt unknown
- 2011-09-27 PL PL11761085T patent/PL2691088T3/pl unknown
- 2011-09-27 EA EA201370181A patent/EA025610B1/ru unknown
- 2011-09-27 WO PCT/EP2011/066746 patent/WO2012038553A1/fr active Application Filing
- 2011-09-27 UA UAA201311023A patent/UA110512C2/ru unknown
- 2011-09-27 CA CA2830703A patent/CA2830703C/fr active Active
- 2011-09-27 CN CN201180069698.7A patent/CN103458883B/zh active Active
- 2011-09-27 DK DK11761085.7T patent/DK2691088T3/en active
- 2011-09-27 RS RS20150382A patent/RS54022B1/en unknown
- 2011-09-27 EP EP11761085.7A patent/EP2691088B1/fr active Active
- 2011-09-27 AU AU2011306879A patent/AU2011306879B2/en active Active
- 2011-09-27 JP JP2014501454A patent/JP5701445B2/ja active Active
- 2011-09-27 MX MX2013011242A patent/MX2013011242A/es active IP Right Grant
- 2011-09-27 ES ES11761085.7T patent/ES2538011T3/es active Active
- 2011-09-27 MA MA36264A patent/MA34975B1/fr unknown
- 2011-09-27 BR BR112013024457-7A patent/BR112013024457A2/pt not_active Application Discontinuation
- 2011-09-27 SG SG2013068671A patent/SG193426A1/en unknown
- 2011-09-27 US US14/008,092 patent/US9315448B2/en active Active
- 2011-09-27 NZ NZ615613A patent/NZ615613A/en unknown
-
2013
- 2013-09-15 IL IL228444A patent/IL228444A/en active IP Right Grant
- 2013-09-25 CO CO13228235A patent/CO6771455A2/es unknown
-
2014
- 2014-02-24 HK HK14101759.3A patent/HK1188715A1/xx unknown
-
2015
- 2015-06-03 HR HRP20150596TT patent/HRP20150596T1/hr unknown
- 2015-06-09 SM SM201500131T patent/SMT201500131B/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA42678B1 (fr) | Nouveaux analogues nucléosidiques substitués à cycle aromatique bicyclique 6-6 pour une utilisation en tant qu'inhibiteurs de prmt5 | |
PH12017501306A1 (en) | Inhibitors of histone demethylases | |
MA51204B1 (fr) | Formes pharmaceutiques comprenant un inhibiteur de la kallicréine plasmatique | |
MY155317A (en) | Benzene sulfonamide thiazole and oxazole compounds | |
MA39211B1 (fr) | Composés tricycliques comme agents anti-cancers | |
MA34819B1 (fr) | Dérivés bicyclo[3.2.1]octylamide et leurs utilisations | |
MA35085B1 (fr) | Procede de traitement d'une nephropathie induite par les produits de contraste | |
MA33488B1 (fr) | Motifs de modification chimique pour des inhibiteurs et mimétiques de miarn | |
CL2012002944A1 (es) | Compuestos derivados de amino-pirimidinas; composiciones farmacéuticas que los comprenden; y su uso para el tratamiento de una enfermedad afección seleccionada de trastornos neuromusculares, esclerosis lateral amiotrófica, miastenia grave, entre otras. | |
CL2012002945A1 (es) | Compuestos derivados de amino-piridazinas; composiciones farmacéuticas que los comprenden; y su uso para el tratamiento de una enfermedad afección seleccionada de trastornos neuromusculares, esclerosis lateral amiotrófica, miastenia grave, entre otras. | |
MA35132B1 (fr) | 4-aryl-n-phényl-1,3,5-triazine-2- amines contenant un groupe sulfoximine | |
MY158757A (en) | Viral inhibitor composition for in vivo threpeutic use | |
MA35342B1 (fr) | Composés de-pipéridinyle utiles comme inhibiteurs de la tankyrase | |
MA33302B1 (fr) | 2, 4-diaminopyrimidines pour le traitement de maladies caracterisees par une proliferation cellulaire excessive ou anormale | |
MA46101A (fr) | Modulateurs allostériques positifs du récepteur muscarinique m1 | |
RS53209B (en) | PHARMACEUTICAL COMPOSITION FOR VIRAL HEPATITIS C PROTEASE INHIBITOR | |
TW200745122A (en) | New compounds I | |
MA37886A1 (fr) | Nouvelles pyridinones bicycliques | |
MA35716B1 (fr) | Formulations pharmaceutiques | |
MA38679A1 (fr) | Modulateurs du récepteur de cxcr7 | |
MA34840B1 (fr) | Dérivés monoterpènes de chalcone ou de dihydrochalcone, et leur utilisation en tant qu'agents de dépigmentation | |
MA34946B1 (fr) | Nouvelles benzodioxolepipérazines | |
TW200745133A (en) | New compounds II | |
MA44965A (fr) | Dérivés de pyridinyle, compositions pharmaceutiques et utilisations de ceux-ci en tant qu'inhibiteurs d'aoc3 | |
MA34709B1 (fr) | Compositions pharmaceutiques |